mirvetuximab
immunogen
['mirasol', 'ovarian']
late-breaking abstract session at #asco23 with dr. kathleen moore covering phase iii mirasol study initial report of mivetuximab soravtansine in platinum-resistant, advanced high-grade fr-alpha expressing #ovariancancers. hall d1 at 7:30am 
Creating Aha! Moments In Healthcare
IDEOlogy Health is leading the change in how HCPs stay up-to-date.